Therapeutic Discovery MicroRNA-199 a-3 p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration

microRNAs (miRNA,miR)playan important role in cancer cell growthandmigration;however, thepotential roles of miRNAs in osteosarcoma remain largely uncharacterized. By applying a miRNAmicroarray platform and unsupervised hierarchical clustering analysis, we found that several miRNAs have altered expression levels in osteosarcoma cell lines and tumor tissues when compared with normal human osteoblasts. Three miRNAs, miR-199a-3p, miR-127-3p, and miR-376c, were significantly decreased in osteosarcoma cell lines, whereas miR-151-3p and miR-191 were increased in osteosarcoma cell lines in comparison with osteoblasts. Transfection of precursor miR-199a-3p into osteosarcoma cell lines significantly decreased cell growth and migration, thus indicating that the inhibition effect is associatedwith an increase in theG1-phase and a decrease of the S-phase cell population. In addition, we observed decreasedmTOR and Stat3 expression in miR-199a-3p transfected cells. This study provides new insights formiRNAs in osteosarcoma and suggests thatmiR-199a-3p mayplay a functional role in osteosarcoma cell growth andproliferation. RestoringmiR-199a-3p’s functionmay provide therapeutic benefits in osteosarcoma. Mol Cancer Ther; 10(8); 1337–45. 2011 AACR.

[1]  Jonathan A. Lee,et al.  A Quantitative, Facile, and High-Throughput Image-Based Cell Migration Method Is a Robust Alternative to the Scratch Assay , 2011, Journal of biomolecular screening.

[2]  Thomas Tuschl,et al.  miRNAs in human cancer , 2011, The Journal of pathology.

[3]  K. Kelnar,et al.  Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44 , 2010, Nature Medicine.

[4]  Feng-jun Wang,et al.  Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. , 2010, Gynecologic oncology.

[5]  W. De,et al.  Functional and biological analysis of Bcl-xL expression in human osteosarcoma. , 2010, Bone.

[6]  C. Croce,et al.  MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. , 2010, Cancer research.

[7]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[8]  R. Xavier,et al.  Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA‐1 in Met expression , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  D. Epstein,et al.  Targeting of Integrin β1 and Kinesin 2α by MicroRNA 183* , 2009, The Journal of Biological Chemistry.

[10]  J. Qu,et al.  MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.

[11]  G. Merlino,et al.  MicroRNA reexpression as differentiation therapy in cancer. , 2009, The Journal of clinical investigation.

[12]  G. Tsujimoto,et al.  Identification of novel microRNA targets based on microRNA signatures in bladder cancer , 2009, International journal of cancer.

[13]  R. Gorlick,et al.  Novel therapeutic agents for osteosarcoma , 2009, Expert review of anticancer therapy.

[14]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[15]  P. Comoglio,et al.  MicroRNAs impair MET-mediated invasive growth. , 2008, Cancer research.

[16]  J. Uney,et al.  Twist-1 regulates the miR-199a/214 cluster during development , 2008, Nucleic acids research.

[17]  A. Palmieri,et al.  Comparison between osteoblasts derived from human dental pulp stem cells and osteosarcoma cell lines , 2008, Cell biology international.

[18]  Ji Young Kim,et al.  MicroRNA miR-199a* Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)* , 2008, Journal of Biological Chemistry.

[19]  S. Bielack,et al.  Osteosarcoma: the same old drugs or more? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T O Nielsen,et al.  MicroRNA expression signature of human sarcomas , 2008, Oncogene.

[21]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[22]  S. Grant,et al.  Targeting multiple arms of the apoptotic regulatory machinery. , 2007, Cancer research.

[23]  J. Bradner,et al.  SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation , 2006, Clinical Cancer Research.

[24]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[25]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[26]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[27]  A. Palmieri,et al.  A comparison between genetic portraits of normal osteoblasts and osteosarcoma cell lines. , 2009, Indian journal of dental research : official publication of Indian Society for Dental Research.

[28]  R. Gorlick,et al.  Therapy for Osteosarcoma , 2008, Paediatric drugs.

[29]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[30]  H. Blau,et al.  Tumor suppression by RNA from the 3' untranslated region of alpha-tropomyosin. , 1993, Cell.